| Ytd | 80.50% | |
| 1y | 231.23% |
| Open | 9.78 | Prev Close | 9.57 | Low | 9.38 | High | 9.79 | Mkt Cap | 520.63M |
| Vol | 123.59K | Avg Vol | 1.62M | EPS | -0.91 | P/E | -10.52 | Forward P/E | -3.96 |
| Beta | 0.09 | Short Ratio | 2.94 | Inst. Own | 17.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 9.49 | 200-d Avg | 7.15 | 1yr Est | 7.00 |
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Immix Biopharma , (“ Imm
ATLANTA, July 20, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Immix Bioph
Philadelphia, Pennsylvania--(Newsfile Corp. - July 20, 2026) - Kehoe Law Firm, P.C. is investigating
BOSTON, July 20, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Immix Biopharma (Nasdaq:
https://www.statnews.com/2026/07/20/ronald-fischer-rhode-island-fugitive-richard-graydon-biotech/ As
Wall Street analysts make changes to top stocks. Check our analyst ratings page for all updates. VAL
Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst r
On Tuesday, 120 companies set new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
During Wednesday's trading, 517 companies set new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
Tuesday's session saw 729 companies set new 52-week lows.